Find Support on Your Journey

Landing Page Draft

What disease community should we include next? 

Latest News

October 23, 2025

Boehringer’s Jascayd gains NMPA approval for idiopathic pulmonary fibrosis – Pharmaceutical Business review –

October 23, 2025

RYR 1 Gene Mutation in Motor Neuron Disease: A 10‐Year Case Observation – Wiley Online Library

October 23, 2025

Scanning the tongue to detect and track Motor Neurone Disease – UQ News

October 23, 2025

Location and amount of joint involvement differentiates rheumatoid arthritis into different clinical subsets – Nature

October 22, 2025

JASCAYD® (nerandomilast) approved in China for the treatment of idiopathic pulmonary fibrosis (IPF) – Boehringer Ingelheim

Looking for a Clinical Trial?

As of February 1, 2026

1096 Lung Cancer Clinical Trials are now recruiting

845 Breast Cancer Clinical Trials are now recruiting

607 Colorectal Cancer Clinical Trials are now recruiting

447 Prostate Cancer Clinical Trials are now recruiting

429 Pancreatic Cancer Clinical Trials are now recruiting

Source:  clinicaltrials.gov